Health Care·Life Sciences Tools & Services·$174.6B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.41 | N/A | +1.60% |
management commentary, guidance changes, and full analysis available with Pro.
| +1.60% |
Tone: Confident
Overall, management conveyed confidence in the company's current performance. They emphasized the strength of their product offerings and market position.
Management expressed satisfaction with the EPS performance.
They highlighted ongoing strength in their core business segments.
Thermo Fisher Scientific's strong EPS performance indicates solid profitability, which likely contributed to the 6.35% rise in stock price. Investors may view this as a positive sign of the company's financial health. However, the lack of revenue data and guidance leaves some uncertainty about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
RAMBUS INC DEL
Jan 30, 2017